Memorial Sloan Kettering Cancer Center

Latest statistics and disclosures from Memorial Sloan Kettering Cancer Center's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are GDX, ORIC, YMAB, and represent 100.00% of Memorial Sloan Kettering Cancer Center's stock portfolio.
  • Reduced shares in these 2 stocks: CRBU, ILMN.
  • Sold out of its positions in CRBU, ILMN.
  • Memorial Sloan Kettering Cancer Center was a net seller of stock by $-3.5M.
  • Memorial Sloan Kettering Cancer Center has $25M in assets under management (AUM), dropping by -22.48%.
  • Central Index Key (CIK): 0001566787

Tip: Access up to 7 years of quarterly data

Positions held by Memorial Sloan Kettering Cancer Center consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center holds 3 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vaneck Etf Trust Gold Miners Etf (GDX) 80.9 $20M 739k 26.91
 View chart
Oric Pharmaceuticals (ORIC) 14.8 $3.6M 602k 6.05
 View chart
Y Mabs Therapeutics (YMAB) 4.2 $1.0M 191k 5.45
 View chart

Past Filings by Memorial Sloan Kettering Cancer Center

SEC 13F filings are viewable for Memorial Sloan Kettering Cancer Center going back to 2020